FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Pierre Lefèbvre

Research Profile

Chemicals & Drugs

Disorders

Procedures

Devices

Insulin Infusion Systems

Concepts & Ideas

Risk Factors

Co-author Network

Publications

TOP 3
R R Radermecker; JC Philips; BJ Jandrain; Nicolas Paquot; Pierre J Lefèbvre; André J Scheen
[Brain, a gluco-dependent organ: toxic effects of hypoglycaemia and hyperglycaemia].
Nicolas Paquot; JC Philips; Régis P Radermecker; Pierre J Lefèbvre
[Recent advances in the management of diabetes mellitus].
Pierre J Lefèbvre
[Metformin, fifty years since the arrival of this molecule!].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Pierre Lefèbvre (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: R R Radermecker; JC Philips; BJ Jandrain; Nicolas Paquot; Pierre J Lefèbvre; André J Scheen
[Brain, a gluco-dependent organ: toxic effects of hypoglycaemia and hyperglycaemia].
Revue médicale de Liège 2008;63(5-6):280-6.
2007: Nicolas Paquot; JC Philips; Régis P Radermecker; Pierre J Lefèbvre
[Recent advances in the management of diabetes mellitus].
Revue médicale de Liège 2007;62(5-6):317-23.
2007: Pierre J Lefèbvre
[Metformin, fifty years since the arrival of this molecule!].
Journées annuelles de diabétologie de l'Hôtel-Dieu 2007;():1-3.
2005: Jacques Damas; Nancy Garbacki; Pierre J Lefèbvre
Does insulin release kinins in rats?
European journal of pharmacology 2005;525(1-3):154-60.
2005: André J Scheen; Pierre J Lefèbvre
[Proactive study: secondary cardiovascular prevention with pioglitazione in type 2 diabetic patients].
Revue médicale de Liège 2005;60(11):896-901.
2005: André J Scheen; Pierre J Lefèbvre
[Diabetes mellitus: epilogue].
Revue médicale de Liège 2005;60(5-6):628-31.
2005: Pierre J Lefèbvre
[Diabetes yesterday, today and tomorrow. The action of the International Diabetes Federation].
Revue médicale de Liège 2005;60(5-6):273-7.
2004: Jacques Damas; Nancy Garbacki; Pierre J Lefèbvre
The kallikrein-kinin system, angiotensin converting enzyme inhibitors and insulin sensitivity.
Diabetes/metabolism research and reviews 2004;20(4):288-97.
2004: MR Letiexhe; Claude Desaive; Pierre J Lefèbvre; André J Scheen
Intact cross-talk between insulin secretion and insulin action after postgastroplasty recovery of ideal body weight in severely obese patients.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2004;28(6):821-3.
2004: Pierre J Lefèbvre
[Glucagon 2004: homage to Roger Assan].
Journées annuelles de diabétologie de l'Hôtel-Dieu 2004;():105-10.
2003: Pierre J Lefèbvre
[Prevention of deafness].
Revue médicale de Liège 2003;58(4):225-8.
2002: Pierre J Lefèbvre
The intriguing diversity of the glucagon gene products.
Current diabetes reports 2002;2(3):201-2.
2002: André J Scheen; Nicolas Paquot; BJ Jandrain; Pierre J Lefèbvre
[Postprandial hyperglycemia. I. Physiopathology, clinical consequences and dietary management].
Revue médicale de Liège 2002;57(3):138-41.
2002: Nicolas Paquot; André J Scheen; Mirjam Dirlewanger; Pierre J Lefèbvre; Luc Tappy
Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients.
Obesity research 2002;10(3):129-34.
2000: Nicolas Paquot; Philippe Schneiter; André J Scheen; Pierre J Lefèbvre; L Tappy
Assessment of postprandial hepatic glycogen synthesis from uridine diphosphoglucose kinetics in obese and lean non-diabetic subjects.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2000;24(10):1297-302.
2000: André J Scheen; M Rorive; F Estrella; Laurent Weekers; Pierre J Lefèbvre
[Guidelines for the treatment of arterial hypertension in diabetic patients].
Revue médicale de Liège 2000;55(5):376-82.
2000: Nicolas Paquot; André J Scheen; Pierre J Lefèbvre
[GLycemic control in the diabetic patient. Recommendations after the DCCT and UKPDI studies].
Revue médicale de Liège 2000;55(5):372-5.
2000: André J Scheen; Pierre J Lefèbvre
Antiobesity pharmacotherapy in the management of type 2 diabetes.
Diabetes/metabolism research and reviews 2000;16(2):114-24.
1999: Françoise Luyckx; A J Scheen; Pierre J Lefèbvre
Non-alcoholic steatohepatitis.
Lancet 1999;354(9186):1298-9.
1999: André J Scheen; Pierre J Lefèbvre
Troglitazone: antihyperglycemic activity and potential role in the treatment of type 2 diabetes.
Diabetes care 1999;22(9):1568-77.
1999: AJ Scheen; Nicolas Paquot; Pierre J Lefèbvre
[Glucotoxicity and lipotoxicity, two implicated accomplices in the vicious circle of type 2 diabetes].
Revue médicale de Liège 1999;54(6):535-8.
1999: André J Scheen; MR Letiexhe; Pierre J Lefèbvre
Minimal influence of the time interval between injection of regular insulin and food intake on blood glucose control of type 1 diabetic patients on a basal-bolus insulin scheme.
Diabetes & metabolism 1999;25(2):157-62.
1999: André J Scheen; Françoise Luyckx; Claude Desaive; Pierre J Lefèbvre
Severe/extreme obesity: a medical disease requiring a surgical treatment?
Acta clinica Belgica 1999;54(3):154-61.
1999: I Geronooz; André J Scheen; Pierre J Lefèbvre
[Gestational diabetes: physiopathology and prognostic significance for the mother].
Revue médicale de Liège 1999;54(5):434-9.
1999: Françoise Luyckx; A J Scheen; Pierre J Lefèbvre
[Obesity and women: esthetic preoccupation or medical problem?].
Revue médicale de Liège 1999;54(4):262-7.
1999: Françoise Luyckx; André J Scheen; MR Letiexhe; Claude Desaive; J Gielen; Pierre J Lefèbvre
[How I treat ... an individual with severe obesity and metabolic abnormalities with gastroplasty].
Revue médicale de Liège 1999;54(3):138-42.
1999: A J Scheen; Nicolas Paquot; MR Letiexhe; Pierre J Lefèbvre
[Thiazolidinediones].
Journées annuelles de diabétologie de l'Hôtel-Dieu 1999;():213-29.
1998: Françoise Luyckx; André J Scheen; Ana M Proenza; A Donny Strosberg; Pierre J Lefèbvre; JE Gielen
Influence of the A-->G (-3826) uncoupling protein-1 gene (UCP1) variant on the dynamics of body weight before and after gastroplasty in morbidly obese subjects.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1998;22(12):1244-5.
1998: Régis P Radermecker; André J Scheen; MR Letiexhe; Pierre J Lefèbvre; Patrick De Mol
[Viral implications in the etiopathogenesis of type 1 diabetes: current update].
Revue médicale de Liège 1998;53(10):597-602.
1998: André J Scheen; Pierre J Lefèbvre
[Lessons from the "United Kingdom Prospective Diabetes Study"].
Revue médicale de Liège 1998;53(9):576-8.
1998: AJ Scheen; K Triches; Françoise Luyckx; MR Letiexhe; Pierre J Lefèbvre
[Pharma clinics. How I treat...a diabetic patient with severe obesity].
Revue médicale de Liège 1998;53(7):386-9.
1998: André J Scheen; Pierre J Lefèbvre
[Pharmaco-economics of type 2 diabetes].
Revue médicale de Liège 1998;53(5):285-9.
1998: JC Philips; André J Scheen; E Firre; M Robin; P Cambier; Pierre J Lefèbvre
[Clinical case of the month. Galloping nephropathy in a patient with type 2 diabetes].
Revue médicale de Liège 1998;53(4):171-4.
1998: Françoise Luyckx; Claude Desaive; Albert Thiry; Walthère Dewé; André J Scheen; JE Gielen; Pierre J Lefèbvre
Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1998;22(3):222-6.
1998: André J Scheen; Pierre J Lefèbvre
Oral antidiabetic agents. A guide to selection.
Drugs 1998;55(2):225-36.
1998: Pierre J Lefèbvre; A J Scheen
The postprandial state and risk of cardiovascular disease.
Diabetic medicine : a journal of the British Diabetic Association 1998;15 Suppl 4():S63-8.
1997: Françoise Luyckx; André J Scheen; Jacques Gielen; Pierre J Lefèbvre
[The adrenergic beta-3 receptor: a role in the genetic predisposition to obesity and diabetes?].
Revue médicale de Liège 1997;52(11):703-8.
1997: Françoise Luyckx; André J Scheen; Jacques Gielen; Pierre J Lefèbvre
[How I investigate...the insulin resistance syndrome using biological markers].
Revue médicale de Liège 1997;52(10):686-91.
1997: Françoise Luyckx; André J Scheen; Jacques Gielen; Pierre J Lefèbvre
[From leptin, a signal from the adipocyte to the brain, to the neurobiology of obesity].
Revue médicale de Liège 1997;52(10):644-8.
1997: André J Scheen; Nicolas Paquot; Pierre J Lefèbvre
[How I investigate the new criteria for the diagnosis of diabetes mellitus].
Revue médicale de Liège 1997;52(9):606-9.
1997: MR Letiexhe; André J Scheen; Pierre J Lefèbvre
Plasma leptin levels, insulin secretion, clearance and action on glucose metabolism in anorexia nervosa.
Eating and weight disorders : EWD 1997;2(2):79-86.
1997: JC Philips; MR Letiexhe; Nicolas Paquot; André J Scheen; Pierre J Lefèbvre
[How I investigate... a patient newly diagnosed with/or at risk of diabetes type 1].
Revue médicale de Liège 1997;52(5):363-6.
1997: Pierre J Lefèbvre
[Diabetes in the elderly patient].
Revue médicale de Liège 1997;52(4):205-8.
1997: F Bustin; S R Pestieau; Nicolas Paquot; André J Scheen; Pierre J Lefèbvre
[Energy expenditure in man].
Revue médicale de Liège 1997;52(2):101-4.
1996: Jean-François Gautier; F Pirnay; M Lacroix; F Mosora; A J Scheen; G Cathelineau; Pierre J Lefèbvre
Changes in breath 13CO2/12CO2 during exercise of different intensities.
Journal of applied physiology (Bethesda, Md. : 1985) 1996;81(3):1096-102.
1996: A J Scheen; Pierre J Lefèbvre
Insulin action in man.
Diabetes & metabolism 1996;22(2):105-10.
1995: A J Scheen; M R Letiexhe; Pierre J Lefèbvre
Short administration of metformin improves insulin sensitivity in android obese subjects with impaired glucose tolerance.
Diabetic medicine : a journal of the British Diabetic Association 1995;12(11):985-9.
1995: Jean-François Gautier; A Scheen; Pierre J Lefèbvre
Exercise in the management of non-insulin-dependent (type 2) diabetes mellitus.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1995;19 Suppl 4():S58-61.
1995: F Pirnay; A J Scheen; Jean-François Gautier; M Lacroix; F Mosora; Pierre J Lefèbvre
Exogenous glucose oxidation during exercise in relation to the power output.
International journal of sports medicine 1995;16(7):456-60.
1995: A J Scheen; Nicolas Paquot; MR Letiexhe; G Paolisso; M J Castillo; Pierre J Lefèbvre
Glucose metabolism in obese subjects: lessons from OGTT, IVGTT and clamp studies.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1995;19 Suppl 3():S14-20.
1995: A J Scheen; M R Letiexhe; Pierre J Lefèbvre
Effects of metformin in obese patients with impaired glucose tolerance.
Diabetes/metabolism reviews 1995;11 Suppl 1():S69-80.
1995: A J Scheen; MR Letiexhe; Nicolas Paquot; Pierre J Lefèbvre
[Clinical case of the month. Prolonged spontaneous remission of a typical type 1 diabetes].
Revue médicale de Liège 1995;50(9):363-4.
1995: M J Castillo; A J Scheen; Pierre J Lefèbvre
Treatment with insulin infusion pumps and ketoacidotic episodes: from physiology to troubleshooting.
Diabetes/metabolism reviews 1995;11(2):161-77.
1995: A J Scheen; Pierre J Lefèbvre
[The unstable diabetic patient: from physiopathology to treatment].
Revue médicale de Liège 1995;50(6):249-53.
1995: Pierre J Lefèbvre
Glucagon and its family revisited.
Diabetes care 1995;18(5):715-30.
1995: Y Biessaux; Nicolas Paquot; A J Scheen; Pierre J Lefèbvre
[Clinical case of the month. Apropos of a case of ectopic ACTH secretion].
Revue médicale de Liège 1995;50(2):55-6.
1995: MR Letiexhe; A J Scheen; P L Gèrard; Claude Desaive; Pierre J Lefèbvre
Postgastroplasty recovery of ideal body weight normalizes glucose and insulin metabolism in obese women.
The Journal of clinical endocrinology and metabolism 1995;80(2):364-9.
1995: M J Castillo; A J Scheen; Pierre J Lefèbvre
Amylin/islet amyloid polypeptide: biochemistry, physiology, patho-physiology.
Diabète & métabolisme 1995;21(1):3-25.
1995: A J Scheen; Pierre J Lefèbvre
Antihyperglycaemic agents. Drug interactions of clinical importance.
Drug safety : an international journal of medical toxicology and drug experience 1995;12(1):32-45.
1994: A J Scheen; Nicolas Paquot; M J Castillo; Pierre J Lefèbvre
How to measure insulin action in vivo.
Diabetes/metabolism reviews 1994;10(2):151-88.
1994: M J Castillo; A J Scheen; MR Letiexhe; Pierre J Lefèbvre
How to measure insulin clearance.
Diabetes/metabolism reviews 1994;10(2):119-50.
1994: Bernard Duysinx; A J Scheen; Nicolas Paquot; C Daubresse; M Castillo; Pierre J Lefèbvre
[Type 2 insulin-dependent diabetes: patient characteristics and effects of insulin therapy].
Revue médicale de Liège 1994;49(6):305-23.
1994: MR Letiexhe; A J Scheen; Paul Gérard; Claude Desaive; Pierre J Lefèbvre
Insulin secretion, clearance and action before and after gastroplasty in severely obese subjects.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1994;18(5):295-300.
1994: Jean-François Gautier; F Pirnay; B Jandrain; M Lacroix; F Mosora; A J Scheen; G Cathelineau; Pierre J Lefèbvre
Availability of glucose ingested during muscle exercise performed under acipimox-induced lipolysis blockade.
European journal of applied physiology and occupational physiology 1994;68(5):406-12.
1994: Vincent Geenen; Henri Martens; E Vandersmissen; O Kecha; A Benhida; N Cormann-Goffin; Pierre J Lefèbvre; P Franchimont
Thymic neuroendocrine self peptides and T cell selection.
Advances in experimental medicine and biology 1994;355():21-6.
1993: MR Letiexhe; A J Scheen; Paul Gérard; B H Bastens; J Pirotte; Jacques Belaiche; Pierre J Lefèbvre
Insulin secretion, clearance, and action on glucose metabolism in cirrhotic patients.
The Journal of clinical endocrinology and metabolism 1993;77(5):1263-8.
1993: A J Scheen; B J Jandrain; D M Humblet; C B Jaminet; Ulysse J Gaspard; Pierre J Lefèbvre
Effects of a 1-year treatment with a low-dose combined oral contraceptive containing ethinyl estradiol and cyproterone acetate on glucose and insulin metabolism.
Fertility and sterility 1993;59(4):797-802.
1993: Jean-François Gautier; F Pirnay; B Jandrain; M Lacroix; F Mosora; A J Scheen; Pierre J Lefèbvre
Endogenous substrate oxidation during exercise and variations in breath 13CO2/12CO2.
Journal of applied physiology (Bethesda, Md. : 1985) 1993;74(1):133-8.
1992: L Van Gaal; G Krzentowski; R Rottiers; E Couturier; G Michel; Pierre J Lefèbvre
[Transition from insulin U-40 to insulin U-100: the Belgian experience].
Diabète & métabolisme 1992;18(4):317-21.
1992: Pierre J Lefèbvre
Pancreatic transplantation: why, when and who?
Diabetologia 1992;35(5):494-7.
1992: Pierre J Lefèbvre; A J Scheen
Management of non-insulin-dependent diabetes mellitus.
Drugs 1992;44 Suppl 3():29-38.
1991: Pierre J Lefèbvre; F Mosora; M Lacroix; F Pirnay; A Scheen; G Krzentowski; B Jandrain; Jean-François Gautier; N Pallikarakis; J P Riou
Use of 13C substrates for metabolic studies in exercise: methodological considerations.
Journal of applied physiology (Bethesda, Md. : 1985) 1991;71(5):2059-61.
1991: A J Scheen; J Guiot; M P Stassen; B Jandrain; N Paquot; Pierre J Lefèbvre
[ Change of insulin U40 to insulin U100: comparison of blood insulin and blood sugar in the diabetic patient].
Revue médicale de Liège 1991;46(4):181-7.
1989: A J Scheen; J Gillet; J Rosenthaler; J Guiot; P Henrivaux; B Jandrain; Pierre J Lefèbvre
Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in type 1 (insulin-dependent) diabetic patients.
Diabetologia 1989;32(11):801-9.
1989: N Paquot; J Guiot; A J Scheen; Pierre J Lefèbvre
[The treatment of diabetic ketoacidosis in 1989].
Revue médicale de Liège 1989;44(15-16):477-83.
1989: A J Scheen; Pierre J Lefèbvre
Insulin versus insulin plus sulfonylureas in type 2 diabetic patients with secondary failure to sulfonylureas.
Diabetes research and clinical practice 1989;6(4):S33-42; discussion S42-3.
1988: A J Scheen; M Castillo; Pierre J Lefèbvre
Insulin sensitivity in anorexia nervosa: a mirror image of obesity?
Diabetes/metabolism reviews 1988;4(7):681-90.
1987: A J Scheen; P Henrivaux; B Jandrain; Pierre J Lefèbvre
U-100 insulin gives some protection against metabolic deterioration due to CSII interruption.
Diabetes care 1987;10(6):707-11.
1987: M Castillô; A J Scheen; G Paolisso; Pierre J Lefèbvre
The addition of glipizide to insulin therapy in type-II diabetic patients with secondary failure to sulfonylureas is useful only in the presence of a significant residual insulin secretion.
Acta endocrinologica 1987;116(3):364-72.
1987: J Gerard; I Hillebrand; Pierre J Lefèbvre
Assessment of the clinical efficacy and tolerance of two new alpha-glucosidase inhibitors in insulin-treated diabetics.
International journal of clinical pharmacology, therapy, and toxicology 1987;25(9):483-8.
1987: A J Scheen; P Henrivaux; B Jandrain; G Paolisso; Pierre J Lefèbvre
Prevention of metabolic alterations by insulin supplements administered either before or after 2-h nocturnal interruption of CSII.
Diabetes care 1987;10(5):567-72.
1987: A Chachati; R von Frenckell; J Foidart-Willems; J P Godon; Pierre J Lefèbvre
Variability of albumin excretion in insulin-dependent diabetics.
Diabetic medicine : a journal of the British Diabetic Association 1987;4(5):441-5.
1987: Pierre J Lefèbvre; G Paolisso; A J Scheen; J C Henquin
Pulsatility of insulin and glucagon release: physiological significance and pharmacological implications.
Diabetologia 1987;30(7):443-52.
1986: J Gerard; B Jandrain; F Pirnay; N Pallikarakis; G Krzentowski; M Lacroix; F Mosora; A S Luyckx; Pierre J Lefèbvre
Utilization of oral sucrose load during exercise in humans. Effect of the alpha-glucosidase inhibitor acarbose.
Diabetes 1986;35(11):1294-301.
1986: A Chachati; J Foidart-Willems; J P Godon; Pierre J Lefèbvre
[Microalbuminuria and early detection of diabetic nephropathy].
Revue médicale de Liège 1986;41(4):117-21.
1986: Pierre J Lefèbvre; F Pirnay; N Pallikarakis; G Krzentowski; B Jandrain; F Mosora; M Lacroix; A S Luyckx
Metabolic availability of carbohydrates ingested during, before, or after muscular exercise.
Diabetes/metabolism reviews 1986;1(4):483-500.
1984: A Scheen; M Castillo; B Jandrain; G Krzentowski; P Henrivaux; A S Luyckx; Pierre J Lefèbvre
Metabolic alterations after a two-hour nocturnal interruption of a continuous subcutaneous insulin infusion.
Diabetes care 1984;7(4):338-42.
1983: G Krzentowski; A Scheen; M Castillo; A S Luyckx; Pierre J Lefèbvre
A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 1. Metabolic and hormonal consequences and scheme for a prompt return to adequate control.
Diabetologia 1983;24(5):314-8.
1983: A J Scheen; G Krzentowski; M Castillo; Pierre J Lefèbvre; A S Luyckx
A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 2. Marked attenuation of the metabolic deterioration by somatostatin.
Diabetologia 1983;24(5):319-25.
1981: G Krzentowski; F Pirnay; N Pallikarakis; A S Luyckx; M Lacroix; F Mosora; Pierre J Lefèbvre
Glucose utilization during exercise in normal and diabetic subjects. The role of insulin.
Diabetes 1981;30(12):983-9.